Global and China Human Somatotropin Market Insights, Forecast to 2027

Publisher Name :
Date: 03-Aug-2021
No. of pages: 147
Inquire Before Buying

Market Analysis and Insights: Global and China Human Somatotropin Market

This report focuses on global and China Human Somatotropin market.

In 2020, the global Human Somatotropin market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Human Somatotropin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Human Somatotropin Scope and Market Size

Human Somatotropin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Somatotropin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Human Somatotropin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Powder

- Solvent

Segment by Application

- Growth Hormone Deficiency (GHD)

- Turner Syndrome

- Chronic Renal Insufficiency

- Prader Willi Syndrome

- Small for Gestational Age

- SHOX Deficiency

- Others

By Region

- North America

- - United States

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Brazil

- Middle East & Africa

- - Turkey

- - GCC Countries

- - Egypt

- - South Africa

By Company

- Novo Nordisk

- Pfizer

- Eli Lilly

- Merck Serono

- F. Hoffmann-La Roche

- Ferring Pharmaceuticals

- GeneScience Pharmaceuticals

- Ipsen

- LG Life Sciences

- Sandoz International

- Anhui Anke Biotechnology

Global and China Human Somatotropin Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Human Somatotropin Product Introduction
1.2 Market by Type
1.2.1 Global Human Somatotropin Market Size Growth Rate by Type
1.2.2 Powder
1.2.3 Solvent
1.3 Market by Application
1.3.1 Global Human Somatotropin Market Size Growth Rate by Application
1.3.2 Growth Hormone Deficiency (GHD)
1.3.3 Turner Syndrome
1.3.4 Chronic Renal Insufficiency
1.3.5 Prader Willi Syndrome
1.3.6 Small for Gestational Age
1.3.7 SHOX Deficiency
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Somatotropin Market Size, Estimates and Forecasts
2.1.1 Global Human Somatotropin Revenue 2016-2027
2.1.2 Global Human Somatotropin Sales 2016-2027
2.2 Global Human Somatotropin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Human Somatotropin Historical Market Size by Region (2016-2021)
2.3.1 Global Human Somatotropin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Human Somatotropin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Human Somatotropin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Human Somatotropin Sales Forecast by Region (2022-2027)
2.4.2 Global Human Somatotropin Revenue Forecast by Region (2022-2027)
3 Global Human Somatotropin Competitor Landscape by Players
3.1 Global Top Human Somatotropin Manufacturers by Sales
3.1.1 Global Human Somatotropin Sales by Manufacturer (2016-2021)
3.1.2 Global Human Somatotropin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Human Somatotropin Manufacturers by Revenue
3.2.1 Key Human Somatotropin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Human Somatotropin Revenue by Manufacturers (2016-2021)
3.2.3 Global Human Somatotropin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Human Somatotropin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Human Somatotropin Revenue in 2020
3.2.6 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Human Somatotropin Price by Manufacturers
3.4 Global Human Somatotropin Manufacturing Base Distribution, Product Types
3.4.1 Human Somatotropin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Somatotropin Product Type
3.4.3 Date of International Manufacturers Enter into Human Somatotropin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Human Somatotropin Market Size by Type (2016-2021)
4.1.1 Global Human Somatotropin Sales by Type (2016-2021)
4.1.2 Global Human Somatotropin Revenue by Type (2016-2021)
4.1.3 Human Somatotropin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Human Somatotropin Market Size Forecast by Type (2022-2027)
4.2.1 Global Human Somatotropin Sales Forecast by Type (2022-2027)
4.2.2 Global Human Somatotropin Revenue Forecast by Type (2022-2027)
4.2.3 Human Somatotropin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Human Somatotropin Market Size by Application (2016-2021)
5.1.1 Global Human Somatotropin Sales by Application (2016-2021)
5.1.2 Global Human Somatotropin Revenue by Application (2016-2021)
5.1.3 Human Somatotropin Price by Application (2016-2021)
5.2 Human Somatotropin Market Size Forecast by Application (2022-2027)
5.2.1 Global Human Somatotropin Sales Forecast by Application (2022-2027)
5.2.2 Global Human Somatotropin Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Somatotropin Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Human Somatotropin Market Size YoY Growth 2016-2027
6.1.1 China Human Somatotropin Sales YoY Growth 2016-2027
6.1.2 China Human Somatotropin Revenue YoY Growth 2016-2027
6.1.3 China Human Somatotropin Market Share in Global Market 2016-2027
6.2 China Human Somatotropin Market Size by Players (International and Local Players)
6.2.1 China Top Human Somatotropin Players by Sales (2016-2021)
6.2.2 China Top Human Somatotropin Players by Revenue (2016-2021)
6.3 China Human Somatotropin Historic Market Review by Type (2016-2021)
6.3.1 China Human Somatotropin Sales Market Share by Type (2016-2021)
6.3.2 China Human Somatotropin Revenue Market Share by Type (2016-2021)
6.3.3 China Human Somatotropin Price by Type (2016-2021)
6.4 China Human Somatotropin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Human Somatotropin Sales Forecast by Type (2022-2027)
6.4.2 China Human Somatotropin Revenue Forecast by Type (2022-2027)
6.4.3 China Human Somatotropin Price Forecast by Type (2022-2027)
6.5 China Human Somatotropin Historic Market Review by Application (2016-2021)
6.5.1 China Human Somatotropin Sales Market Share by Application (2016-2021)
6.5.2 China Human Somatotropin Revenue Market Share by Application (2016-2021)
6.5.3 China Human Somatotropin Price by Application (2016-2021)
6.6 China Human Somatotropin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Human Somatotropin Sales Forecast by Application (2022-2027)
6.6.2 China Human Somatotropin Revenue Forecast by Application (2022-2027)
6.6.3 China Human Somatotropin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Human Somatotropin Market Size YoY Growth 2016-2027
7.2 North America Human Somatotropin Market Facts & Figures by Country
7.2.1 North America Human Somatotropin Sales by Country (2016-2021)
7.2.2 North America Human Somatotropin Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
7.2.5 Mexico
8 Asia Pacific
8.1 Asia Pacific Human Somatotropin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Human Somatotropin Market Facts & Figures by Region
8.2.1 Asia Pacific Human Somatotropin Sales by Region (2016-2021)
8.2.2 Asia Pacific Human Somatotropin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Thailand
8.2.10 Malaysia
8.2.11 Philippines
8.2.12 Vietnam
9 Europe
9.1 Europe Human Somatotropin Market Size YoY Growth 2016-2027
9.2 Europe Human Somatotropin Market Facts & Figures by Country
9.2.1 Europe Human Somatotropin Sales by Country (2016-2021)
9.2.2 Europe Human Somatotropin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 UK
9.2.6 Italy
10 Latin America
10.1 Latin America Human Somatotropin Market Size YoY Growth 2016-2027
10.2 Latin America Human Somatotropin Market Facts & Figures by Country
10.2.1 Latin America Human Somatotropin Sales by Country (2016-2021)
10.2.2 Latin America Human Somatotropin Revenue by Country (2016-2021)
10.2.3 Brazil
11 Middle East and Africa
11.1 Middle East and Africa Human Somatotropin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Human Somatotropin Market Facts & Figures by Country
11.2.1 Middle East and Africa Human Somatotropin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Human Somatotropin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 GCC Countries
11.2.5 Egypt
11.2.6 South Africa
12 Company Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Corporation Information
12.1.2 Novo Nordisk Description and Business Overview
12.1.3 Novo Nordisk Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novo Nordisk Human Somatotropin Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Human Somatotropin Products Offered
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Description and Business Overview
12.3.3 Eli Lilly Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Human Somatotropin Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Merck Serono
12.4.1 Merck Serono Corporation Information
12.4.2 Merck Serono Description and Business Overview
12.4.3 Merck Serono Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck Serono Human Somatotropin Products Offered
12.4.5 Merck Serono Recent Development
12.5 F. Hoffmann-La Roche
12.5.1 F. Hoffmann-La Roche Corporation Information
12.5.2 F. Hoffmann-La Roche Description and Business Overview
12.5.3 F. Hoffmann-La Roche Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 F. Hoffmann-La Roche Human Somatotropin Products Offered
12.5.5 F. Hoffmann-La Roche Recent Development
12.6 Ferring Pharmaceuticals
12.6.1 Ferring Pharmaceuticals Corporation Information
12.6.2 Ferring Pharmaceuticals Description and Business Overview
12.6.3 Ferring Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ferring Pharmaceuticals Human Somatotropin Products Offered
12.6.5 Ferring Pharmaceuticals Recent Development
12.7 GeneScience Pharmaceuticals
12.7.1 GeneScience Pharmaceuticals Corporation Information
12.7.2 GeneScience Pharmaceuticals Description and Business Overview
12.7.3 GeneScience Pharmaceuticals Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GeneScience Pharmaceuticals Human Somatotropin Products Offered
12.7.5 GeneScience Pharmaceuticals Recent Development
12.8 Ipsen
12.8.1 Ipsen Corporation Information
12.8.2 Ipsen Description and Business Overview
12.8.3 Ipsen Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Ipsen Human Somatotropin Products Offered
12.8.5 Ipsen Recent Development
12.9 LG Life Sciences
12.9.1 LG Life Sciences Corporation Information
12.9.2 LG Life Sciences Description and Business Overview
12.9.3 LG Life Sciences Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 LG Life Sciences Human Somatotropin Products Offered
12.9.5 LG Life Sciences Recent Development
12.10 Sandoz International
12.10.1 Sandoz International Corporation Information
12.10.2 Sandoz International Description and Business Overview
12.10.3 Sandoz International Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sandoz International Human Somatotropin Products Offered
12.10.5 Sandoz International Recent Development
12.11 Novo Nordisk
12.11.1 Novo Nordisk Corporation Information
12.11.2 Novo Nordisk Description and Business Overview
12.11.3 Novo Nordisk Human Somatotropin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novo Nordisk Human Somatotropin Products Offered
12.11.5 Novo Nordisk Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Human Somatotropin Industry Trends
13.2 Human Somatotropin Market Drivers
13.3 Human Somatotropin Market Challenges
13.4 Human Somatotropin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Somatotropin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Human Somatotropin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Powder
Table 3. Major Manufacturers of Solvent
Table 4. Global Human Somatotropin Market Size Growth Rate by Application (2021-2027) & (MT)
Table 5. Global Human Somatotropin Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Human Somatotropin Sales by Regions (2016-2021) & (MT)
Table 7. Global Human Somatotropin Sales Market Share by Regions (2016-2021)
Table 8. Global Human Somatotropin Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Human Somatotropin Sales Forecast by Region (2022-2027) & (MT)
Table 10. Global Human Somatotropin Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Human Somatotropin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Human Somatotropin Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Human Somatotropin Sales by Manufacturers (2016-2021) (MT)
Table 14. Global Human Somatotropin Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Human Somatotropin Manufacturers by Revenue (US$ Million) in 2020
Table 16. Human Somatotropin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Human Somatotropin Revenue Share by Manufacturers (2016-2021)
Table 18. Global Human Somatotropin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Human Somatotropin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Somatotropin as of 2020)
Table 20. Key Manufacturers Human Somatotropin Price (2016-2021) (USD/MT)
Table 21. Human Somatotropin Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Somatotropin Product Type
Table 23. Date of International Manufacturers Enter into Human Somatotropin Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Somatotropin Sales by Type (2016-2021) (MT)
Table 26. Global Human Somatotropin Sales Share by Type (2016-2021)
Table 27. Global Human Somatotropin Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Human Somatotropin Revenue Share by Type (2016-2021)
Table 29. Human Somatotropin Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
Table 30. Global Human Somatotropin Sales Forecast by Type (2022-2027) & (MT)
Table 31. Global Human Somatotropin Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Human Somatotropin Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Human Somatotropin Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Human Somatotropin Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
Table 35. Global Human Somatotropin Sales by Application (2016-2021) (MT)
Table 36. Global Human Somatotropin Sales Share by Application (2016-2021)
Table 37. Global Human Somatotropin Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Human Somatotropin Revenue Share by Application (2016-2021)
Table 39. Human Somatotropin Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
Table 40. Global Human Somatotropin Sales Forecast by Application (2022-2027) & (MT)
Table 41. Global Human Somatotropin Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Human Somatotropin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Human Somatotropin Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Human Somatotropin Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
Table 45. China Human Somatotropin Sales (MT) of Key Companies (2016-2021)
Table 46. China Human Somatotropin Sales Share by Company (2016-2021)
Table 47. China Human Somatotropin Revenue (US$ Million) by Company (2016-2021)
Table 48. China Human Somatotropin Revenue Share by Company (2016-2021)
Table 49. China Human Somatotropin Sales (MT) by Type (2016-2021)
Table 50. China Human Somatotropin Sales Share by Type (2016-2021)
Table 51. China Human Somatotropin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Human Somatotropin Price (USD/MT) by Type (2016-2021)
Table 53. China Human Somatotropin Sales (MT) by Type (2022-2027)
Table 54. China Human Somatotropin Sales Share by Type (2022-2027)
Table 55. China Human Somatotropin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Human Somatotropin Revenue Share by Type (2022-2027)
Table 57. China Human Somatotropin Price (USD/MT) by Type (2022-2027)
Table 58. China Human Somatotropin Sales (MT) by Application (2016-2021)
Table 59. China Human Somatotropin Sales Share by Application (2016-2021)
Table 60. China Human Somatotropin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Human Somatotropin Price (USD/MT) by Application (2016-2021)
Table 62. China Human Somatotropin Sales (MT) by Application (2022-2027)
Table 63. China Human Somatotropin Sales Share by Application (2022-2027)
Table 64. China Human Somatotropin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Human Somatotropin Revenue Share by Application (2022-2027)
Table 66. China Human Somatotropin Price (USD/MT) by Application (2022-2027)
Table 67. North America Human Somatotropin Sales by Country (2016-2021) & (MT)
Table 68. North America Human Somatotropin Sales Market Share by Country (2016-2021)
Table 69. North America Human Somatotropin Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Human Somatotropin Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Human Somatotropin Sales by Region (2016-2021) & (MT)
Table 72. Asia Pacific Human Somatotropin Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Human Somatotropin Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Human Somatotropin Revenue Market Share by Region (2016-2021)
Table 75. Europe Human Somatotropin Sales by Country (2016-2021) & (MT)
Table 76. Europe Human Somatotropin Sales Market Share by Country (2016-2021)
Table 77. Europe Human Somatotropin Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Human Somatotropin Revenue Market Share by Country (2016-2021)
Table 79. Latin America Human Somatotropin Sales by Country (2016-2021) & (MT)
Table 80. Latin America Human Somatotropin Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Human Somatotropin Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Human Somatotropin Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Human Somatotropin Sales by Country (2016-2021) & (MT)
Table 84. Middle East and Africa Human Somatotropin Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Human Somatotropin Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Human Somatotropin Revenue Market Share by Country (2016-2021)
Table 87. Novo Nordisk Corporation Information
Table 88. Novo Nordisk Description and Business Overview
Table 89. Novo Nordisk Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 90. Novo Nordisk Human Somatotropin Product
Table 91. Novo Nordisk Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Business Overview
Table 94. Pfizer Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. Eli Lilly Corporation Information
Table 98. Eli Lilly Description and Business Overview
Table 99. Eli Lilly Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 100. Eli Lilly Product
Table 101. Eli Lilly Recent Development
Table 102. Merck Serono Corporation Information
Table 103. Merck Serono Description and Business Overview
Table 104. Merck Serono Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 105. Merck Serono Product
Table 106. Merck Serono Recent Development
Table 107. F. Hoffmann-La Roche Corporation Information
Table 108. F. Hoffmann-La Roche Description and Business Overview
Table 109. F. Hoffmann-La Roche Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 110. F. Hoffmann-La Roche Product
Table 111. F. Hoffmann-La Roche Recent Development
Table 112. Ferring Pharmaceuticals Corporation Information
Table 113. Ferring Pharmaceuticals Description and Business Overview
Table 114. Ferring Pharmaceuticals Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 115. Ferring Pharmaceuticals Product
Table 116. Ferring Pharmaceuticals Recent Development
Table 117. GeneScience Pharmaceuticals Corporation Information
Table 118. GeneScience Pharmaceuticals Description and Business Overview
Table 119. GeneScience Pharmaceuticals Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 120. GeneScience Pharmaceuticals Product
Table 121. GeneScience Pharmaceuticals Recent Development
Table 122. Ipsen Corporation Information
Table 123. Ipsen Description and Business Overview
Table 124. Ipsen Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 125. Ipsen Product
Table 126. Ipsen Recent Development
Table 127. LG Life Sciences Corporation Information
Table 128. LG Life Sciences Description and Business Overview
Table 129. LG Life Sciences Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 130. LG Life Sciences Product
Table 131. LG Life Sciences Recent Development
Table 132. Sandoz International Corporation Information
Table 133. Sandoz International Description and Business Overview
Table 134. Sandoz International Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 135. Sandoz International Product
Table 136. Sandoz International Recent Development
Table 137. Anhui Anke Biotechnology Corporation Information
Table 138. Anhui Anke Biotechnology Description and Business Overview
Table 139. Anhui Anke Biotechnology Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 140. Anhui Anke Biotechnology Product
Table 141. Anhui Anke Biotechnology Recent Development
Table 142. Human Somatotropin Market Trends
Table 143. Human Somatotropin Market Drivers
Table 144. Human Somatotropin Market Challenges
Table 145. Human Somatotropin Market Restraints
Table 146. Human Somatotropin Customers List
Table 147. Human Somatotropin Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Somatotropin Product Picture
Figure 2. Global Human Somatotropin Sales Market Share by Type in 2020 & 2027
Figure 3. Powder Product Picture
Figure 4. Solvent Product Picture
Figure 5. Global Human Somatotropin Sales Market Share by Application in 2020 & 2027
Figure 6. Growth Hormone Deficiency (GHD)
Figure 7. Turner Syndrome
Figure 8. Chronic Renal Insufficiency
Figure 9. Prader Willi Syndrome
Figure 10. Small for Gestational Age
Figure 11. SHOX Deficiency
Figure 12. Others
Figure 13. Human Somatotropin Report Years Considered
Figure 14. Global Human Somatotropin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Human Somatotropin Market Size 2016-2027 (US$ Million)
Figure 16. Global Human Somatotropin Sales 2016-2027 (MT)
Figure 17. Global Human Somatotropin Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Human Somatotropin Sales Market Share by Region (2016-2021)
Figure 19. Global Human Somatotropin Sales Market Share by Region in 2020
Figure 20. Global Human Somatotropin Revenue Market Share by Region (2016-2021)
Figure 21. Global Human Somatotropin Revenue Market Share by Region in 2020
Figure 22. Global Human Somatotropin Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Human Somatotropin Revenue in 2020
Figure 24. Human Somatotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Human Somatotropin Sales Market Share by Type (2016-2021)
Figure 26. Global Human Somatotropin Sales Market Share by Type in 2020
Figure 27. Global Human Somatotropin Revenue Market Share by Type (2016-2021)
Figure 28. Global Human Somatotropin Revenue Market Share by Type in 2020
Figure 29. Global Human Somatotropin Sales Market Share by Application (2016-2021)
Figure 30. Global Human Somatotropin Sales Market Share by Application in 2020
Figure 31. Global Human Somatotropin Revenue Market Share by Application (2016-2021)
Figure 32. Global Human Somatotropin Revenue Market Share by Application in 2020
Figure 33. China Human Somatotropin Sales Growth Rate 2016-2027 (MT)
Figure 34. China Human Somatotropin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. China Human Somatotropin Market Share in Global Market 2016-2027
Figure 36. China 5 and 10 Largest Human Somatotropin Players Market Share by Revenue in Human Somatotropin in 2020
Figure 37. China Human Somatotropin Revenue Share by Type (2016-2021)
Figure 38. China Human Somatotropin Revenue Growth Rate by Type in 2016 & 2020
Figure 39. China Human Somatotropin Revenue Share by Application (2016-2021)
Figure 40. China Human Somatotropin Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Human Somatotropin Sales Growth Rate 2016-2021 (MT)
Figure 42. North America Human Somatotropin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Human Somatotropin Sales Market Share by Country in 2020
Figure 44. North America Human Somatotropin Revenue Market Share by Country in 2020
Figure 45. United States Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 46. United States Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 48. Canada Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Mexico Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 50. Mexico Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Europe Human Somatotropin Sales Growth Rate 2016-2021 (MT)
Figure 52. Europe Human Somatotropin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 53. Europe Human Somatotropin Sales Market Share by Country in 2020
Figure 54. Europe Human Somatotropin Revenue Market Share by Country in 2020
Figure 55. Germany Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 56. Germany Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. France Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 58. France Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. UK Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 60. UK Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Italy Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 62. Italy Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Russia Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 64. Russia Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Asia Pacific Human Somatotropin Sales Growth Rate 2016-2021 (MT)
Figure 66. Asia Pacific Human Somatotropin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 67. Asia Pacific Human Somatotropin Sales Market Share by Region in 2020
Figure 68. Asia Pacific Human Somatotropin Revenue Market Share by Region in 2020
Figure 69. China Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 70. China Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Japan Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 72. Japan Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. South Korea Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 74. South Korea Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. India Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 76. India Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Australia Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 78. Australia Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 80. Indonesia Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 82. Thailand Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 84. Malaysia Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 86. Philippines Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 88. Vietnam Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Human Somatotropin Sales Growth Rate 2016-2021 (MT)
Figure 90. Latin America Human Somatotropin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Human Somatotropin Sales Market Share by Country in 2020
Figure 92. Latin America Human Somatotropin Revenue Market Share by Country in 2020
Figure 93. Brazil Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 94. Brazil Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Human Somatotropin Sales Growth Rate 2016-2021 (MT)
Figure 96. Middle East and Africa Human Somatotropin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Human Somatotropin Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Human Somatotropin Revenue Market Share by Country in 2020
Figure 99. Turkey Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 100. Turkey Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. GCC Countries Human Somatotropin Sales Growth Rate (2016-2021) (MT)
Figure 102. GCC Countries Human Somatotropin Revenue Growth Rate (2016-2021) (US$ Million)
Figu
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs